The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
CORONARY INTERVENTIONS
Correlates of non-target vessel-related adverse events in patients with ST-segment elevation myocardial infarction: insights from five-year follow-up of the EXAMINATION trial
EuroIntervention 2018;13:1939-1945 published online December 2017. DOI: 10.4244/EIJ-D-17-00608
Giosafat Spitaleri1, MD; Elisabetta Moscarella1, MD; Salvatore Brugaletta1*, MD, PhD; Alberto Pernigotti1, MD; Luis Ortega-Paz1, MD; Josep Gomez-Lara2, MD, PhD; Angel Cequier2, MD; Andrés Iñiguez3, MD; Antonio Serra4, MD; Pilar Jiménez-Quevedo5, MD; Vicente Mainar6, MD; Gianluca Campo7, MD; Maurizio Tespili8, MD; Peter den Heijer9, MD; Armando Bethencourt10, MD; Nicolás Vazquez11, MD; Marco Valgimigli12, MD, PhD; Patrick W. Serruys13, MD, PhD; Manel Sabaté
1. University Hospital Clínic, Cardiovascular Clinic Institute, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; 2. Department of Cardiology, University Hospital of Bellvitge, Barcelona, Spain; 3. Department of Cardiol
Aims: The aim of this substudy was to determine the five-year correlates of non-TV-related adverse events (AE) in STEMI patients included in the EXAMINATION trial.